Drug Database
Back to search

Switzerland· 66137001

Rapiscan 400 µg/ 5 ml, Injektionslösung

A regadenoson product containing regadenosonum, registered in Switzerland by GE Healthcare AG and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC C01EB21

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedRapiscan 400 µg/ 5 ml, Injektionslösu…ATCC01EB21REGISTER NO.66137001PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about regadenosonumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Regadenoson is registered in 13 of 19 countries.

Countries holding a registration under ATC C01EB21 (regadenoson), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 9 of them publish a price we can compare per daily dose
Search regadenoson products by name

Regadenoson · ATC C01EB21

13 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
regadenosonum
Manufacturer
GE Healthcare AG
Country
Switzerland (CH)
ATC code
C01EB21
ATC class
Regadenoson
Defined daily dose
0.4 mg, P
Swissmedic category
A
Reimbursed
Yes
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680661370013
    Durchstf 5 ml
    CHF 114.6

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

6 interactions on record for regadenoson.

Graded by severity as the source publishes them — 6 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check regadenoson against other medicinesHow interaction checks work

Regadenoson · interactions on record

6 records

  • 6 moderate

Most severe, free to view

  • DipyridamoleB01AC07moderate
  • DipyridamolC01DX29moderate
  • TheophyllinC01EB28moderate
  • CaffeineN06BC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Regadenoson in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All regadenoson products

Authorised across Europe · EMA

The same active substance is authorised in 4 EEA countries. Names it is sold under:

  • United Kingdom (Northern Ireland) · Rapiscan
  • Iceland · Rapiscan
  • Liechtenstein · Rapiscan
  • Norway · Rapiscan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cf6b7be5-fdc3-4258-8a87-c4e969bf92e1
GET /v1/drugs/cf6b7be5-fdc3-4258-8a87-c4e969bf92e1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "regadenosonum 400 mcg",
  "valid_from": "2018-02-01",
  "limitations": null,
  "galenic_form": "Inj Lös 400 mcg/5ml",
  "therapeutic_area": null,
  "sl_inclusion_date": "2018-02-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about regadenoson.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console